Skip to content

Observational research on efficacy and safety of Yokukansan in behavioral and psychological symptoms of dementia with Lewy bodies.

Observational research on efficacy and safety of Yokukansan in behavioral and psychological symptoms of dementia with Lewy bodies. - Observational research on Yokukansan in behavioral and psychological symptoms of dementia with Lewy bodies.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000008407
Enrollment
100
Registered
2012-07-11
Start date
2012-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia with Lewy bodies patient having behavioral and psychological symptoms

Interventions

None listed

Sponsors

Keimei Memorial Hospital
Lead Sponsor
Tsumura &amp
Collaborator
Co.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient who was diagnosed dementia with Lewy bodies and has BPSD Patient who was prescribed TJ-54

Exclusion criteria

Exclusion criteria: When a patient refuses to join the research When a doctor judged a patient not appropriate to join the research based on medical or social reasons

Design outcomes

Primary

MeasureTime frame
Changes in neuropsychiatric inventory (NPI) score before and after TJ-54 treatment

Secondary

MeasureTime frame
Changes in serum potassium level before and after TJ-54 treatment Incidence rate of adverse reaction

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026